Correlation Between LIFE + and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LIFE + and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIFE + and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LIFE BANC SPLIT and Pfizer Inc, you can compare the effects of market volatilities on LIFE + and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIFE + with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIFE + and Pfizer.

Diversification Opportunities for LIFE + and Pfizer

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between LIFE and Pfizer is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding LIFE BANC SPLIT and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and LIFE + is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIFE BANC SPLIT are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of LIFE + i.e., LIFE + and Pfizer go up and down completely randomly.

Pair Corralation between LIFE + and Pfizer

Assuming the 90 days horizon LIFE BANC SPLIT is expected to generate 2.0 times more return on investment than Pfizer. However, LIFE + is 2.0 times more volatile than Pfizer Inc. It trades about 0.04 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.05 per unit of risk. If you would invest  549.00  in LIFE BANC SPLIT on September 23, 2024 and sell it today you would earn a total of  16.00  from holding LIFE BANC SPLIT or generate 2.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

LIFE BANC SPLIT  vs.  Pfizer Inc

 Performance 
       Timeline  
LIFE BANC SPLIT 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in LIFE BANC SPLIT are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, LIFE + may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

LIFE + and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LIFE + and Pfizer

The main advantage of trading using opposite LIFE + and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIFE + position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind LIFE BANC SPLIT and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios